Astrana Health Inc. (ASTH)
NASDAQ
37.14
+0.14 (+0.38%)
Closed
Oct 7, 2026
Day's Range
36.6537.66
52 wk Range
18.0851.60
Financial Statements - ASTH - Astrana Health Inc.
Revenue
3.18B▲ 56.4%
Net Income
24.07M▼ 51.8%Net Margin 0.8%
EBITDA
135.35M▼ 4.1%
Free Cash Flow
104.49M▲ 136.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 3.18B | 2.03B | 1.38B | 1.14B | 773.91M | 370.24M |
| Cost of Goods | 2.84B | 1.76B | 1.17B | 944.68M | 596.14M | 348.54M |
| Gross Profit | 341.53M | 271.38M | 214.95M | 199.47M | 177.77M | 21.70M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 78.52M | 89.35M | 84.61M | 104.26M | 98.17M | 6.08M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -1.14M | 10.05M | 7.11M | -11.70M | -16.60M | 4.90M |
| Pre Tax Income | 39.60M | 80.81M | 89.83M | 86.61M | 77.74M | 8.86M |
| Income Tax | 15.53M | 30.88M | 31.98M | 40.87M | 31.69M | 9.18M |
| Net Income | 24.07M | 49.93M | 57.84M | 45.74M | 46.05M | -314K |
| EPS Basic | 0.46 | 0.91 | 1.3 | 1.09 | 1.69 | 1.04 |
| EPS Diluted | 0.46 | 0.9 | 1.29 | 1.08 | 1.63 | 1.01 |
| Basic Shares Outstanding | 49.07M | 47.41M | 46.70M | 44.99M | 43.70M | 36.40M |
| Diluted Shares Outstanding | 49.07M | 47.41M | 46.70M | 44.99M | 43.70M | 36.40M |
| Ebit | 89.53M | 113.91M | 105.94M | 94.53M | 83.14M | 11.39M |
| Ebitda | 135.35M | 141.11M | 128.26M | 133.35M | 109.21M | 40.27M |
| Net Income Continuous Operations | 24.07M | 49.93M | 57.84M | 45.74M | 46.05M | 122.08M |
| Minority Interests | -1.58M | -6.78M | 2.86M | -570K | 22.86M | -23.43M |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
